U.S. judge: Injection sites don’t violate federal drug laws | TribLIVE.com
Pennsylvania

U.S. judge: Injection sites don’t violate federal drug laws

Associated Press
1754882_web1_1754882-8efdac37d3e846c9ac5dd67701aa7f15
AP
U.S. Attorney for the Eastern District of Pennsylvania William McSwain speaks with members of the media at a news conference at the U.S. Custom House in Philadelphia. A federal judge ruled Wednesday, Oct. 2, that a Philadelphia nonprofit’s proposal to open the nation’s first supervised injection site does not violate federal law,the first court decision in the country to definitively weigh in on the matter.

PHILADELPHIA —

A federal judge ruled Wednesday that supervised injection sites designed to prevent overdoses do not violate federal drug laws, giving advocates in Philadelphia and perhaps elsewhere a boost in their efforts to open them.

U.S. District Judge Gerald A. McHugh said there’s no evidence that Congress intended 1980s-era drug laws to cover sites where people could inject drugs and have medical help nearby if they need it.

“Safe injection sites were not considered by Congress and could not have been, because their use as a possible harm reduction strategy among opioid users had not yet entered public discourse,” McHugh said in his ruling.

U.S. Attorney William McSwain, an appointee of Republican President Donald Trump, had gone to court in Philadelphia to try to block the plan, calling the goal “laudable” but supporters misguided.

Mayor Jim Kenney, District Attorney Larry Krasner and former Pennsylvania Gov. Ed Rendell, all Democrats, believe the program would reduce the city’s 1,100 annual overdose deaths and help steer users into treatment.

Rendell helped found the nonprofit group that would run the program, called Safehouse, after the overdose death of a family friend.

Ronda Goldfein, a Safehouse vice president, said the group would seek clarity from McHugh in the next few weeks on whether to move forward with plans to open sites across the city.

The Justice Department appeared likely to challenge the decision. Deputy Attorney General Jeffrey A. Rosen said the department was disappointed and would “take all available steps to pursue further judicial review.”

“Any attempt to open illicit drug injection sites in other jurisdictions while this case is pending will continue to be met with immediate action by the department,” he said in a statement.

The issue has divided public officials in Philadelphia and around the nation, although similar sites are in use in Canada and Europe. Supervised injection sites are also being considered in other U.S. cities including Seattle, New York, San Francisco and Somerville, Mass., just outside of Boston.

Under the Safehouse plan, people struggling with addiction could bring drugs to the clinic-like setting, use them in a partitioned bay and get help from nearby medical help if they overdose. They would also be counseled about treatment and other health services.

“It’s a better option than having people die in streets and alleyways and fields. And it will also help the community,” said Debbie Howland of Drexel Hill, who lost a daughter to an overdose death last year.

She volunteers several days a week in Philadelphia’s drug-ravaged Kensington neighborhood, and bemoaned that small children have to walk past dirty needles and “devastated” users on their way to school.

“With 70,000 people dying a year (nationally), you’ve got to do something,” she said Wednesday.

However, some neighborhood groups and city council members representing the area oppose the plan and have vowed to keep fighting it.

Safehouse lawyers had argued that it wasn’t clearly illegal under the Controlled Substances Act — which regulates the possession, use and distribution of certain drugs — to stand nearby with life-saving medical help.

McHugh in his ruling agreed.

“The ultimate goal of Safehouse’s proposed operation is to reduce drug use, not facilitate it, and accordingly, (the law) does not prohibit Safehouse’s proposed conduct,” he wrote.

The decision come as federal, state and local authorities pursue billions of dollars in legal damages from pharmaceutical companies that manufactured and marketed opioid products.

Categories: News | Pennsylvania
TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.